Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Journal of Cardiac Failure
|
December 17, 2023
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER
Jawad H Butt, Karola Jering, Rudolf A DE Boer, et al.
European Heart Journal
|
March 30, 2020
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Kieran F Docherty, Pardeep S Jhund, Silvio E Inzucchi, et al.
European Heart Journal
|
May 23, 2023
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER
Jawad H Butt, Toru Kondo, Mingming Yang, et al.
The Lancet. Diabetes & Endocrinology
|
December 2, 2021
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
Peter Rossing, Silvio E Inzucchi, Priya Vart, et al.
Circulation
|
October 12, 2020
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF
Pardeep S Jhund, Scott D Solomon, Kieran F Docherty, et al.
Nature Medicine
|
August 27, 2022
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Pardeep S Jhund, Toru Kondo, Jawad H Butt, et al.
Circulation
|
September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
Kieran F Docherty, Pardeep S Jhund, Inder Anand, et al.
European Heart Journal
|
August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.
Circulation
|
July 17, 2020
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
Alice M Jackson, Pooja Dewan, Inder S Anand, et al.
JAMA
|
March 29, 2020
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Mark C Petrie, Subodh Verma, Kieran F Docherty, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Journal of Cardiac Failure
|
December 17, 2023
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER
Jawad H Butt, Karola Jering, Rudolf A DE Boer, et al.
European Heart Journal
|
March 30, 2020
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Kieran F Docherty, Pardeep S Jhund, Silvio E Inzucchi, et al.
European Heart Journal
|
May 23, 2023
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER
Jawad H Butt, Toru Kondo, Mingming Yang, et al.
The Lancet. Diabetes & Endocrinology
|
December 2, 2021
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
Peter Rossing, Silvio E Inzucchi, Priya Vart, et al.
Circulation
|
October 12, 2020
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF
Pardeep S Jhund, Scott D Solomon, Kieran F Docherty, et al.
Nature Medicine
|
August 27, 2022
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Pardeep S Jhund, Toru Kondo, Jawad H Butt, et al.
Circulation
|
September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
Kieran F Docherty, Pardeep S Jhund, Inder Anand, et al.
European Heart Journal
|
August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.
Circulation
|
July 17, 2020
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
Alice M Jackson, Pooja Dewan, Inder S Anand, et al.
JAMA
|
March 29, 2020
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Mark C Petrie, Subodh Verma, Kieran F Docherty, et al.
Page
of 8